- £1.27bn
- £1.35bn
- £497.50m
- 72
- 29
- 66
- 57
Annual balance sheet for Chemring, fiscal year end - October 31st, GBP millions except per share, conversion factor applied.
2021 October 31st | 2022 October 31st | 2023 October 31st | 2024 October 31st | 2025 October 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 5.8 | 19.8 | 6.4 | 45 | 65.3 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 54.6 | 53.2 | 65.6 | 82.6 | 92.4 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 148 | 181 | 184 | 264 | 322 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 199 | 231 | 242 | 288 | 355 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 532 | 620 | 596 | 692 | 863 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 103 | 114 | 142 | 222 | 201 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 179 | 202 | 218 | 336 | 481 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 353 | 418 | 379 | 356 | 382 |
| Total Liabilities & Shareholders' Equity | 532 | 620 | 596 | 692 | 863 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |